SARTORIUS AG-VORZUG (SRT3.DE) Fundamental Analysis & Valuation

FRA:SRT3 • DE0007165631

Current stock price

213.1 EUR
+1.6 (+0.76%)
Last:

This SRT3.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SRT3.DE Profitability Analysis

1.1 Basic Checks

  • SRT3 had positive earnings in the past year.
  • SRT3 had a positive operating cash flow in the past year.
  • Each year in the past 5 years SRT3 has been profitable.
  • Each year in the past 5 years SRT3 had a positive operating cash flow.
SRT3.DE Yearly Net Income VS EBIT VS OCF VS FCFSRT3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • SRT3 has a Return On Assets of 1.60%. This is in the lower half of the industry: SRT3 underperforms 66.67% of its industry peers.
  • SRT3 has a worse Return On Equity (5.73%) than 61.11% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.97%, SRT3 is doing worse than 66.67% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for SRT3 is below the industry average of 9.34%.
  • The 3 year average ROIC (4.49%) for SRT3 is below the current ROIC(4.97%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.6%
ROE 5.73%
ROIC 4.97%
ROA(3y)1.51%
ROA(5y)3.97%
ROE(3y)6.23%
ROE(5y)15.62%
ROIC(3y)4.49%
ROIC(5y)9.01%
SRT3.DE Yearly ROA, ROE, ROICSRT3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • SRT3 has a worse Profit Margin (4.38%) than 66.67% of its industry peers.
  • In the last couple of years the Profit Margin of SRT3 has declined.
  • SRT3's Operating Margin of 15.34% is in line compared to the rest of the industry. SRT3 outperforms 50.00% of its industry peers.
  • In the last couple of years the Operating Margin of SRT3 has declined.
  • SRT3 has a Gross Margin of 46.26%. This is in the better half of the industry: SRT3 outperforms 66.67% of its industry peers.
  • SRT3's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.34%
PM (TTM) 4.38%
GM 46.26%
OM growth 3Y-16.16%
OM growth 5Y-5.98%
PM growth 3Y-35.4%
PM growth 5Y-13.41%
GM growth 3Y-3.93%
GM growth 5Y-2.18%
SRT3.DE Yearly Profit, Operating, Gross MarginsSRT3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. SRT3.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SRT3 is destroying value.
  • The number of shares outstanding for SRT3 remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, SRT3 has more shares outstanding
  • The debt/assets ratio for SRT3 has been reduced compared to a year ago.
SRT3.DE Yearly Shares OutstandingSRT3.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
SRT3.DE Yearly Total Debt VS Total AssetsSRT3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 2.24 indicates that SRT3 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.24, SRT3 perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
  • SRT3 has a debt to FCF ratio of 10.84. This is a negative value and a sign of low solvency as SRT3 would need 10.84 years to pay back of all of its debts.
  • SRT3 has a Debt to FCF ratio of 10.84. This is in the lower half of the industry: SRT3 underperforms 61.11% of its industry peers.
  • SRT3 has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
  • SRT3 has a Debt to Equity ratio of 1.24. This is in the lower half of the industry: SRT3 underperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 10.84
Altman-Z 2.24
ROIC/WACC0.58
WACC8.55%
SRT3.DE Yearly LT Debt VS Equity VS FCFSRT3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • SRT3 has a Current Ratio of 0.90. This is a bad value and indicates that SRT3 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.90, SRT3 is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.50 indicates that SRT3 may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.50, SRT3 is doing worse than 88.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.5
SRT3.DE Yearly Current Assets VS Current LiabilitesSRT3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. SRT3.DE Growth Analysis

3.1 Past

  • SRT3 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.46%, which is quite impressive.
  • Measured over the past 5 years, SRT3 shows a small growth in Earnings Per Share. The EPS has been growing by 1.76% on average per year.
  • Looking at the last year, SRT3 shows a small growth in Revenue. The Revenue has grown by 4.66% in the last year.
  • The Revenue has been growing by 8.66% on average over the past years. This is quite good.
EPS 1Y (TTM)83.46%
EPS 3Y-20.66%
EPS 5Y1.76%
EPS Q2Q%21.15%
Revenue 1Y (TTM)4.66%
Revenue growth 3Y-5.37%
Revenue growth 5Y8.66%
Sales Q2Q%2.29%

3.2 Future

  • Based on estimates for the next years, SRT3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.39% on average per year.
  • SRT3 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.94% yearly.
EPS Next Y21.83%
EPS Next 2Y21.56%
EPS Next 3Y19.17%
EPS Next 5Y16.39%
Revenue Next Year6.85%
Revenue Next 2Y8.73%
Revenue Next 3Y9.02%
Revenue Next 5Y8.94%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SRT3.DE Yearly Revenue VS EstimatesSRT3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
SRT3.DE Yearly EPS VS EstimatesSRT3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

1

4. SRT3.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 44.58, which means the current valuation is very expensive for SRT3.
  • 72.22% of the companies in the same industry are cheaper than SRT3, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.61, SRT3 is valued quite expensively.
  • A Price/Forward Earnings ratio of 36.59 indicates a quite expensive valuation of SRT3.
  • Based on the Price/Forward Earnings ratio, SRT3 is valued a bit more expensive than the industry average as 72.22% of the companies are valued more cheaply.
  • SRT3's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.79.
Industry RankSector Rank
PE 44.58
Fwd PE 36.59
SRT3.DE Price Earnings VS Forward Price EarningsSRT3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • SRT3's Enterprise Value to EBITDA ratio is in line with the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as SRT3.
Industry RankSector Rank
P/FCF 40.39
EV/EBITDA 20.32
SRT3.DE Per share dataSRT3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as SRT3's earnings are expected to grow with 19.17% in the coming years.
PEG (NY)2.04
PEG (5Y)25.28
EPS Next 2Y21.56%
EPS Next 3Y19.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. SRT3.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.44%, SRT3 is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.56, SRT3 pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.44, SRT3 pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.44%

5.2 History

  • The dividend of SRT3 is nicely growing with an annual growth rate of 15.65%!
Dividend Growth(5Y)15.65%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 32.71% of the earnings are spent on dividend by SRT3. This is a low number and sustainable payout ratio.
  • The dividend of SRT3 is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP32.71%
EPS Next 2Y21.56%
EPS Next 3Y19.17%
SRT3.DE Yearly Income VS Free CF VS DividendSRT3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
SRT3.DE Dividend Payout.SRT3.DE Dividend Payout, showing the Payout Ratio.SRT3.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SRT3.DE Fundamentals: All Metrics, Ratios and Statistics

SARTORIUS AG-VORZUG

FRA:SRT3 (3/25/2026, 5:36:15 PM)

213.1

+1.6 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-03
Earnings (Next)04-23
Inst Owners1.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.96B
Revenue(TTM)3.54B
Net Income(TTM)155.00M
Analysts80
Price Target376.45 (76.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.44%
Yearly Dividend0.73
Dividend Growth(5Y)15.65%
DP32.71%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.19%
Min EPS beat(2)4.83%
Max EPS beat(2)7.55%
EPS beat(4)2
Avg EPS beat(4)-0.57%
Min EPS beat(4)-10.52%
Max EPS beat(4)7.55%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.53%
Min Revenue beat(2)0.24%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)0.75%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)2.67%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.27%
PT rev (3m)8.45%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.75%
EPS NY rev (3m)-3.78%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-1.39%
Valuation
Industry RankSector Rank
PE 44.58
Fwd PE 36.59
P/S 4.51
P/FCF 40.39
P/OCF 19.06
P/B 5.9
P/tB N/A
EV/EBITDA 20.32
EPS(TTM)4.78
EY2.24%
EPS(NY)5.82
Fwd EY2.73%
FCF(TTM)5.28
FCFY2.48%
OCF(TTM)11.18
OCFY5.25%
SpS47.25
BVpS36.15
TBVpS-34.61
PEG (NY)2.04
PEG (5Y)25.28
Graham Number62.35
Profitability
Industry RankSector Rank
ROA 1.6%
ROE 5.73%
ROCE 7%
ROIC 4.97%
ROICexc 5.35%
ROICexgc 20.27%
OM 15.34%
PM (TTM) 4.38%
GM 46.26%
FCFM 11.17%
ROA(3y)1.51%
ROA(5y)3.97%
ROE(3y)6.23%
ROE(5y)15.62%
ROIC(3y)4.49%
ROIC(5y)9.01%
ROICexc(3y)4.83%
ROICexc(5y)9.64%
ROICexgc(3y)16.7%
ROICexgc(5y)28.15%
ROCE(3y)6.33%
ROCE(5y)12.7%
ROICexgc growth 3Y-19.62%
ROICexgc growth 5Y-7.23%
ROICexc growth 3Y-29.84%
ROICexc growth 5Y-12.08%
OM growth 3Y-16.16%
OM growth 5Y-5.98%
PM growth 3Y-35.4%
PM growth 5Y-13.41%
GM growth 3Y-3.93%
GM growth 5Y-2.18%
F-Score7
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 10.84
Debt/EBITDA 3.49
Cap/Depr 105.19%
Cap/Sales 12.49%
Interest Coverage 3
Cash Conversion 86.94%
Profit Quality 254.9%
Current Ratio 0.9
Quick Ratio 0.5
Altman-Z 2.24
F-Score7
WACC8.55%
ROIC/WACC0.58
Cap/Depr(3y)122.42%
Cap/Depr(5y)145.08%
Cap/Sales(3y)13.7%
Cap/Sales(5y)13.08%
Profit Quality(3y)357.39%
Profit Quality(5y)249.46%
High Growth Momentum
Growth
EPS 1Y (TTM)83.46%
EPS 3Y-20.66%
EPS 5Y1.76%
EPS Q2Q%21.15%
EPS Next Y21.83%
EPS Next 2Y21.56%
EPS Next 3Y19.17%
EPS Next 5Y16.39%
Revenue 1Y (TTM)4.66%
Revenue growth 3Y-5.37%
Revenue growth 5Y8.66%
Sales Q2Q%2.29%
Revenue Next Year6.85%
Revenue Next 2Y8.73%
Revenue Next 3Y9.02%
Revenue Next 5Y8.94%
EBIT growth 1Y38.38%
EBIT growth 3Y-20.66%
EBIT growth 5Y2.17%
EBIT Next Year85.03%
EBIT Next 3Y33.54%
EBIT Next 5Y24.23%
FCF growth 1Y-30.23%
FCF growth 3Y23.14%
FCF growth 5Y7.81%
OCF growth 1Y-14.26%
OCF growth 3Y4.46%
OCF growth 5Y10.35%

SARTORIUS AG-VORZUG / SRT3.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.


Can you provide the valuation status for SARTORIUS AG-VORZUG?

ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.


Can you provide the profitability details for SARTORIUS AG-VORZUG?

SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.


What is the valuation of SARTORIUS AG-VORZUG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SARTORIUS AG-VORZUG (SRT3.DE) is 44.58 and the Price/Book (PB) ratio is 5.9.


Can you provide the financial health for SRT3 stock?

The financial health rating of SARTORIUS AG-VORZUG (SRT3.DE) is 1 / 10.